Recombinant multi-species TRAIL/CD253/TNFSF10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRAIL/CD253/TNFSF10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
The Alternative Names of target: A330042I21Rik,APO-2L,APO2L,Apo-2 ligand (Apo-2L),Apo-2L,CD253,Ly81,TANCR,TL2,TNF-related apoptosis-inducing ligand (Protein TRAIL),TNFSF10,TNLG6A,TRAIL,Tnfsf10,Tnlg6a,Trail,Tumor necrosis factor ligand superfamily member 10
Go
to TRAIL/CD253/TNFSF10 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T46084-Ag-1/ GM-Tg-hg-T46084-Ag-2 | Human TRAIL/CD253/TNFSF10 protein | Human |
| GM-Tg-rg-T46084-Ag-1/ GM-Tg-rg-T46084-Ag-2 | Rat TRAIL/CD253/TNFSF10 protein | Rat |
| GM-Tg-mg-T46084-Ag-1/ GM-Tg-mg-T46084-Ag-2 | Mouse TRAIL/CD253/TNFSF10 protein | Mouse |
| GM-Tg-cynog-T46084-Ag-1/ GM-Tg-cynog-T46084-Ag-2 | Cynomolgus/Rhesus macaque TRAIL/CD253/TNFSF10 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T46084-Ag-1/ GM-Tg-felg-T46084-Ag-2 | Feline TRAIL/CD253/TNFSF10 protein | Feline |
| GM-Tg-cang-T46084-Ag-1/ GM-Tg-cang-T46084-Ag-2 | Canine TRAIL/CD253/TNFSF10 protein | Canine |
| GM-Tg-bovg-T46084-Ag-1/ GM-Tg-bovg-T46084-Ag-2 | Bovine TRAIL/CD253/TNFSF10 protein | Bovine |
| GM-Tg-equg-T46084-Ag-1/ GM-Tg-equg-T46084-Ag-2 | Equine TRAIL/CD253/TNFSF10 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T46084-Ag-1/ GM-Tg-hg-T46084-Ag-2;
GM-Tg-rg-T46084-Ag-1/ GM-Tg-rg-T46084-Ag-2;
GM-Tg-mg-T46084-Ag-1/ GM-Tg-mg-T46084-Ag-2; GM-Tg-cynog-T46084-Ag-1/ GM-Tg-cynog-T46084-Ag-2; GM-Tg-felg-T46084-Ag-1/ GM-Tg-felg-T46084-Ag-2; GM-Tg-cang-T46084-Ag-1/ GM-Tg-cang-T46084-Ag-2; GM-Tg-bovg-T46084-Ag-1/ GM-Tg-bovg-T46084-Ag-2; GM-Tg-equg-T46084-Ag-1/ GM-Tg-equg-T46084-Ag-2 |
| Products Name | TRAIL/CD253/TNFSF10 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TRAIL/CD253/TNFSF10 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TRAIL/CD253/TNFSF10 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.